Indian J Dermatol. 2016 Mar-Apr;61(2):163-8. doi: 10.4103/0019-5154.177758.
Assessment of Life Quality Index Among Patients with Acne Vulgaris in a Suburban Population.
Indian journal of dermatology
Neirita Hazarika, Radha K Rajaprabha
Affiliations
Affiliations
- Department of Dermatology, Venereology and STD, Tagore Medical College and Hospital, Chennai, Tamil Nadu, India.
PMID: 27057015
PMCID: PMC4817440 DOI: 10.4103/0019-5154.177758
Abstract
BACKGROUND AND AIMS: Acne vulgaris affects about 85% of adolescents, often extending into adulthood. Psychosocial impact of acne on health-related quality of life (QoL) has been identified, but it remains under-evaluated, especially in Indian patients. This study was aimed to assess the impact of acne and its sequelae on the QoL.
MATERIALS AND METHODS: This was a hospital-based, prospective, cross-sectional study done between June and November 2014 on 114 consenting patients above 15 years of age with acne vulgaris. Acne vulgaris and its sequelae were graded, and QoL was assessed by using Dermatology Life Quality Index (DLQI) questionnaire.
RESULTS: Most cases (64%) were between 15 and 20 years. Females (57%) outnumbered males. Facial lesions (61.4%) and grade II acne were most common. Mean DLQI score was 7.22. DLQI scores were statistically influenced by the age of the patient, duration and grade of acne, acne scar, and postacne hyperpigmentation.
CONCLUSION: This study showed significant impairment of QoL in acne patients. Assurance and counseling along with early treatment of acne vulgaris are important to reduce disease-related psychosocial sequelae and increase the efficacy of treatment.
Keywords: Acne vulgaris; Dermatology Life Quality Index; influencing factors; quality of life
References
- Clin Exp Dermatol. 1994 May;19(3):210-6 - PubMed
- Int J Dermatol. 2007 Oct;46 Suppl 1:36-8 - PubMed
- Health Qual Life Outcomes. 2012 Jun 06;10:60 - PubMed
- Am J Clin Dermatol. 2003;4(12):833-42 - PubMed
- Acta Derm Venereol. 2002;82(2):104-7 - PubMed
- Br J Dermatol. 1978 Jul;99(Suppl 16):18-9 - PubMed
- Clin Exp Dermatol. 2001 Jul;26(5):380-5 - PubMed
- J Invest Dermatol. 2011 Feb;131(2):363-70 - PubMed
- J Dermatol. 2015 Jul;42(7):690-6 - PubMed
- Br J Dermatol. 2004 Jul;151(1):183-9 - PubMed
- Indian J Dermatol Venereol Leprol. 2012 Jul-Aug;78(4):454-8 - PubMed
- Qual Life Res. 1996 Feb;5(1):131-8 - PubMed
- Br J Dermatol. 1998 Nov;139(5):840-5 - PubMed
- An Bras Dermatol. 2011 Nov-Dec;86(6):1113-21 - PubMed
- Br J Dermatol. 1997 Aug;137(2):246-50 - PubMed
- N Z Med J. 1995 Jul 28;108(1004):287-9 - PubMed
- J Health Psychol. 2009 Nov;14(8):1105-18 - PubMed
- J Prim Health Care. 2009 Mar;1(1):20-5 - PubMed
- Dermatol Clin. 2012 Apr;30(2):293-300, ix - PubMed
- J Clin Aesthet Dermatol. 2012 Mar;5(3):51-7 - PubMed
- Saudi Med J. 2006 Jan;27(1):80-2 - PubMed
- Arch Dermatol. 1998 Apr;134(4):454-8 - PubMed
- J Eur Acad Dermatol Venereol. 2006 Jan;20(1):45-50 - PubMed
- Indian J Dermatol. 2015 Jan-Feb;60(1):33-40 - PubMed
- An Bras Dermatol. 2012 Nov-Dec;87(6):862-9 - PubMed
- Am J Clin Dermatol. 2006;7(3):185-92 - PubMed
- Soc Sci Med. 1995 Nov;41(10):1403-9 - PubMed
- Int J Dermatol. 2000 May;39(5):354-7 - PubMed
- Indian J Dermatol Venereol Leprol. 2009 May-Jun;75(3):323-6 - PubMed
- J Eur Acad Dermatol Venereol. 2007 Feb;21(2):219-26 - PubMed
Publication Types